From previous studies, the ratio of the two ER subtypes may be the key factor as to how the ERs regulate the different cellular functions [35], and ERβ increases the efficacy by suppression on cell proliferation, cell apoptosis and cell cycling in breast cancer cells [36]–[38]. The gene discussed is ESR2; the disease is breast carcinoma.